Literature DB >> 27042503

Exchange Transfusion in Severe Falciparum Malaria.

Harshad Chandrakant Dongare1, Khalid Ismail Khatib2.   

Abstract

Malaria is endemic in India with the incidence of P. falciparum Malaria increasing gradually over the last decade. Severe malaria is an acute disease, caused by P. falciparum, but increasingly also by P. vivax with major signs of organ dysfunction and/or high levels of parasitaemia (>10%) in blood smear. Use of exchange transfusion with antimalarial drug therapy as an additional modality of treatment in severe Falciparum malaria is controversial and is unclear. We report a case of severe malaria complicated by multiorgan failure and ARDS. Patient responded well to manual exchange transfusion with standard artesunate-based chemotherapy.

Entities:  

Keywords:  Exchange blood transfusion; Malaria; Plasmodium falciparum

Year:  2016        PMID: 27042503      PMCID: PMC4800569          DOI: 10.7860/JCDR/2016/16341.7190

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Automated erythrocytapheresis in the treatment of severe falciparum malaria.

Authors:  D C Macallan; M Pocock; E Bishop; D H Bevan; J Parker-Williams; T Harrison; G T Robinson
Journal:  J Infect       Date:  1999-11       Impact factor: 6.072

2.  Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis.

Authors:  Mark S Riddle; Jeffrey L Jackson; John W Sanders; David L Blazes
Journal:  Clin Infect Dis       Date:  2002-04-03       Impact factor: 9.079

Review 3.  Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review.

Authors:  P Phillips; S Nantel; W B Benny
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

4.  Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Authors:  Joseph Schwartz; Jeffrey L Winters; Anand Padmanabhan; Rasheed A Balogun; Meghan Delaney; Michael L Linenberger; Zbigniew M Szczepiorkowski; Mark E Williams; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2013-07       Impact factor: 2.821

5.  Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol.

Authors:  Perry J J van Genderen; Dennis A Hesselink; Jacob M Bezemer; Pieter J Wismans; David Overbosch
Journal:  Transfusion       Date:  2009-11-20       Impact factor: 3.157

6.  Exchange blood transfusion in severe falciparum malaria--the debate goes on.

Authors:  C B Panosian
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

7.  [Cerebral tropical malaria with blackwater fever. A current diagnostic and therapeutic problem].

Authors:  K Gyr; B Speck; R Ritz; P Cornu; C D Buckner
Journal:  Schweiz Med Wochenschr       Date:  1974-11-09

8.  Red blood cell exchange transfusion as an adjunct treatment for severe pediatric falciparum malaria, using automated or manual procedures.

Authors:  Fouad N Boctor
Journal:  Pediatrics       Date:  2005-09-15       Impact factor: 7.124

9.  Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria.

Authors:  Annemarie R Kreeftmeijer-Vegter; Mariana de Mendonça Melo; Peter J de Vries; Rob Koelewijn; Jaap J van Hellemond; Perry J J van Genderen
Journal:  Malar J       Date:  2013-03-27       Impact factor: 2.979

  9 in total
  2 in total

1.  Whole blood transfusion improves vascular integrity and increases survival in artemether-treated experimental cerebral malaria.

Authors:  Saba Gul; Flavia L Ribeiro-Gomes; Aline S Moreira; Guilherme S Sanches; Fabiana G Conceição; Cláudio Tadeu Daniel-Ribeiro; Hans C Ackerman; Leonardo J M Carvalho
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 2.  Adjunctive therapy for severe malaria: a review and critical appraisal.

Authors:  Rosauro Varo; Valerie M Crowley; Antonio Sitoe; Lola Madrid; Lena Serghides; Kevin C Kain; Quique Bassat
Journal:  Malar J       Date:  2018-01-24       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.